Innovation Pharmaceuticals Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000.
  • Innovation Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Innovation Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Innovation Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-13
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.